|
Market Closed -
Sao Paulo
20:50:53 05/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 60.60 BRL | -4.99% |
|
-8.18% | -14.54% |
| 10-02 | Jefferies Raises Regeneron Pharmaceuticals Price Target to $930 From $870, Maintains Buy Rating | MT |
| 10-02 | Major drugmakers turn to China for licensing deals | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +0.02% | -3.52% | -0.54% | -5.83% | +6.37% | +36.11% | +111.11% | +395.01% | +1,298.31% | 1,019B | ||
| -1.21% | -6.99% | -8.10% | -3.84% | +22.22% | +34.08% | +60.96% | +58.50% | +112.23% | 610B | ||
| +1.12% | -0.20% | +3.63% | +1.80% | +16.31% | +13.62% | +80.24% | +142.68% | +319.25% | 470B | ||
| -3.30% | -6.15% | -7.18% | +7.70% | +32.57% | +56.45% | +34.69% | +71.00% | +122.20% | 344B | ||
| +1.46% | +1.49% | +0.25% | +6.84% | +8.01% | +22.92% | +42.89% | +1.43% | +48.14% | 336B | ||
| +1.36% | -2.17% | -5.71% | -5.44% | +7.94% | +11.81% | +33.85% | +56.52% | +53.94% | 266B | ||
| +1.92% | -3.22% | -0.12% | -14.70% | -12.78% | -5.48% | +9.93% | +37.02% | +139.32% | 241B | ||
| -0.01% | -3.62% | -7.83% | +7.71% | +23.12% | +35.28% | +52.02% | +90.21% | +140.96% | 218B | ||
| -0.08% | -4.98% | -4.22% | +10.18% | +17.83% | +28.34% | +93.61% | +114.58% | +86.45% | 179B | ||
| +0.94% | -0.58% | -16.31% | -22.08% | -23.07% | -35.27% | -61.23% | -19.45% | +82.96% | 164B | ||
| -1.40% | -4.56% | -3.66% | +12.71% | +10.08% | +0.15% | -18.11% | -35.23% | -19.14% | 156B | ||
| -0.24% | -4.58% | -7.80% | -4.65% | +11.06% | +24.85% | +41.78% | +184.45% | +474.44% | 128B | ||
| -3.83% | -7.94% | -11.99% | +1.17% | +9.03% | +29.39% | +4.24% | -0.57% | +7.34% | 120B | ||
| +1.46% | +6.91% | +0.82% | +16.43% | +11.60% | +24.03% | +105.35% | +361.84% | +452.57% | 107B | ||
| +1.70% | -0.45% | -6.00% | -4.51% | -13.99% | -17.06% | -30.38% | -14.23% | +3.45% | 93.99B | ||
| +1.01% | -4.07% | -3.10% | -10.21% | -2.41% | +10.18% | +18.75% | +3.19% | -15.24% | 93.19B | ||
| +6.95% | +3.01% | +39.62% | +154.78% | +589.08% | +613.27% | +97.35% | -38.81% | - | 81.13B | ||
| -1.19% | -3.43% | -12.23% | +11.04% | -5.88% | +21.08% | -12.59% | +31.87% | +85.04% | 72.54B | ||
| +3.53% | +2.77% | +4.52% | -1.12% | +15.17% | +17.47% | -9.78% | -24.39% | +46.49% | 66.31B | ||
| Average | +0.45% | -2.83% | -2.42% | +8.31% | +38.01% | +48.49% | +34.46% | +74.51% | +191.04% | 250.76B | |
| Weighted average by Cap. | +0.60% | -3.24% | -2.94% | +1.59% | +20.41% | +33.79% | +55.28% | +135.20% | +389.07% |
- Stock Market
- Stocks
- REGN Stock
- REGN34 Stock
- Sector Regeneron Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
















